|
|
Volumn 29, Issue 5, 2002, Pages 711-717
|
|
Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
6 FLUORODOPA;
AROMATIC LEVO AMINO ACID DECARBOXYLASE;
CARRIER PROTEIN;
DOPAMINE;
DOPAMINE TRANSPORTER;
LEVODOPA;
LIGAND;
MONOAMINE TRANSPORTER 2;
TETRABENAZINE;
UNCLASSIFIED DRUG;
CLINICAL MEDICINE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DATA ANALYSIS;
DIAGNOSTIC PROCEDURE;
DISEASE COURSE;
DISEASE SEVERITY;
DOPAMINE UPTAKE;
HUMAN;
IMAGE ANALYSIS;
IMAGING;
INSTRUMENTATION;
NEUROPROTECTION;
NIGRONEOSTRIATAL SYSTEM;
PARKINSON DISEASE;
PATHOLOGY;
PHOTON EMISSION TOMOGRAPHY;
REVIEW;
SINGLE PHOTON EMISSION TOMOGRAPHY;
SYNAPSE;
BRAIN;
DISEASE PROGRESSION;
DOPAMINE;
DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS;
FLUORINE RADIOISOTOPES;
HUMANS;
MEMBRANE GLYCOPROTEINS;
MEMBRANE TRANSPORT PROTEINS;
NERVE TISSUE PROTEINS;
PARKINSON DISEASE;
TOMOGRAPHY, EMISSION-COMPUTED;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
|
|
EID: 0036236472
PISSN: 03406997
EISSN: None
Source Type: Journal
DOI: 10.1007/s00259-002-0814-5 Document Type: Review |
|
Times cited : (23)
|
|
References (0)
|
